Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q1 2021 · 10-Q
Revenue—
Net Income-$711.51K-$711.51KN/M vs Q1 2020 EPS Diluted-$0.01-$0.01N/M vs Q1 2020 Operating Income-$525,269N/M Operating Cash Flow-$303,496N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Oct 31, 2020 · filed Dec 11, 2020 · 41 d after period end